In 2023, Germany led European sold production of oxygen-function amino-compounds, excluding lysine and glutamic acid, valued at 614.68 million euros, followed by Spain and the Netherlands with 350.88 million and 117.11 million euros, respectively. Poland showed the highest year-on-year growth at 6.5%, while Hungary suffered a significant decline of 30.8%. Over the past five years, a variety of growth rates are evident across different countries, showcasing both expansion and contraction in this sector.
Future trends to monitor include continued growth in Germany, driven by its strong industrial base. Increasing demand from the pharmaceutical and specialty chemical industries may propel expansion across Europe, particularly in Poland and the Netherlands. Sustainability and regulatory compliance are likely to shape production strategies and impact market dynamics significantly.
Top countries in Sold Production of Oxygen-Function Amino-Compounds, Except Lysine and Glutamic Acid by Country
| # | 10 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 614,680,000 | 2023 | +3.98% | +9.65% | View data |
| 2 | 2 Spain | 350,880,000 | 2023 | +0.85% | +3.45% | View data |
| 3 | 3 Netherlands | 117,110,000 | 2023 | +18.39% | +29.16% | View data |
| 4 | 4 France | 109,180,000 | 2021 | -53.91% | -13.74% | View data |
| 5 | 5 Italy | 59,779,000 | 2023 | -2.95% | -3.26% | View data |
| 6 | 6 Denmark | 36,639,000 | 2023 | +2.54% | +3.87% | View data |
| 7 | 7 United Kingdom | 32,698,000 | 2023 | -4.64% | +0.72% | View data |
| 8 | 8 Poland | 21,117,000 | 2023 | +4.09% | +6.5% | View data |
| 9 | 9 Belgium | 9,241,900 | 2023 | -12.47% | -10.6% | View data |
| 10 | 10 Czechia | 4,346,000 | 2023 |
